Globus Medical, Inc.
GMED
$91.70
-$2.10-2.24%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.65% | 11.75% | 17.43% | 32.26% | 60.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.65% | 11.75% | 17.43% | 32.26% | 60.62% |
| Cost of Revenue | 0.49% | -3.30% | 16.17% | 53.81% | 88.53% |
| Gross Profit | 26.18% | 20.80% | 18.13% | 21.99% | 47.74% |
| SG&A Expenses | 16.13% | 11.73% | 17.27% | 27.17% | 51.92% |
| Depreciation & Amortization | -0.99% | 0.99% | 17.49% | 55.70% | 133.92% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.68% | 2.17% | 13.54% | 34.72% | 66.87% |
| Operating Income | 83.63% | 86.94% | 44.79% | 18.30% | 28.36% |
| Income Before Tax | 401.21% | 280.43% | 461.28% | 148.76% | -27.01% |
| Income Tax Expenses | 278.85% | 24.33% | -34.73% | 75.38% | -58.28% |
| Earnings from Continuing Operations | 422.28% | 363.08% | 776.83% | 178.51% | -16.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 422.28% | 363.08% | 776.83% | 178.51% | -16.19% |
| EBIT | 83.63% | 86.94% | 44.79% | 18.30% | 28.36% |
| EBITDA | 51.14% | 48.56% | 33.18% | 28.75% | 45.30% |
| EPS Basic | 425.13% | 364.81% | 775.77% | 112.87% | -35.88% |
| Normalized Basic EPS | 117.07% | 75.58% | 34.13% | -5.00% | -18.72% |
| EPS Diluted | 425.84% | 368.77% | 796.24% | 112.66% | -35.72% |
| Normalized Diluted EPS | 117.19% | 74.86% | 33.02% | -5.93% | -18.69% |
| Average Basic Shares Outstanding | -0.37% | -0.16% | 4.28% | 11.73% | 20.09% |
| Average Diluted Shares Outstanding | -0.34% | 0.36% | 5.21% | 12.84% | 20.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |